Michael Böhm mainly investigates Internal medicine, Cardiology, Endocrinology, Heart failure and Surgery. His study in Blood pressure, Endothelium, Myocardial infarction, Coronary artery disease and Renal sympathetic denervation falls under the purview of Internal medicine. His research in Blood pressure intersects with topics in Ambulatory, Denervation and Intensive care medicine.
He works in the field of Cardiology, namely Ejection fraction. His work deals with themes such as Sinus rhythm, Ivabradine, Heart rate and Quality of life, which intersect with Heart failure. His work on Catheter and Angiography as part of general Surgery study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His primary areas of study are Internal medicine, Cardiology, Heart failure, Endocrinology and Blood pressure. He integrates Internal medicine with In patient in his study. His Cardiology research is multidisciplinary, incorporating perspectives in Ivabradine, Clinical trial and Surgery.
His Heart failure research integrates issues from Intensive care medicine, Placebo, Clinical endpoint, Hazard ratio and Heart disease. His works in Angiotensin II, Angiotensin II receptor type 1 and Renin–angiotensin system are all subjects of inquiry into Endocrinology. His Blood pressure research is multidisciplinary, relying on both Anesthesia and Kidney.
Michael Böhm mainly focuses on Internal medicine, Cardiology, Heart failure, Blood pressure and Denervation. Internal medicine and In patient are two areas of study in which Michael Böhm engages in interdisciplinary research. His work in Cardiology covers topics such as Stroke which are related to areas like Cardiovascular outcomes.
His biological study spans a wide range of topics, including Placebo, Ivabradine, Interquartile range and Intensive care medicine. Michael Böhm has included themes like Ambulatory and Kidney in his Blood pressure study. His Denervation research incorporates elements of Renal artery, Ambulatory blood pressure and Sympathectomy, Surgery, Catheter.
His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Ejection fraction and Atrial fibrillation. Michael Böhm connects Internal medicine with In patient in his study. His work carried out in the field of Cardiology brings together such families of science as Stroke, Anesthesia and Blood pressure, Heart rate.
His research integrates issues of Placebo, Ivabradine, Randomized controlled trial and Intensive care medicine in his study of Heart failure. The various areas that he examines in his Ejection fraction study include Tolerability, Interquartile range and Heart transplantation. His Atrial fibrillation study incorporates themes from Cathepsin, Endocrinology and Bradykinin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating endothelial progenitor cells and cardiovascular outcomes.
Nikos Werner;Sonja Kosiol;Tobias Schiegl;Patrick Ahlers.
The New England Journal of Medicine (2005)
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
Holger Thiele;Uwe Zeymer;Franz-Josef Neumann;Miroslaw Ferenc.
The New England Journal of Medicine (2012)
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.
Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redán.
Journal of Hypertension (2013)
Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis
Ulrich Laufs;Nikos Werner;Andreas Link;Matthias Endres.
Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.
Bruno Scheller;Christoph Hehrlein;Wolfgang Bocksch;Wolfgang Rutsch.
The New England Journal of Medicine (2006)
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
Michael Böhm;Karl Swedberg;Michel Komajda;Jeffrey S Borer.
The Lancet (2010)
Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis Evidence for Involvement of the Renin-Angiotensin System
Ascan Warnholtz;Georg Nickenig;Eberhard Schulz;Roland Macharzina.
Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo
Sven Wassmann;Ulrich Laufs;Kirsten Müller;Christian Konkol.
Arteriosclerosis, Thrombosis, and Vascular Biology (2002)
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension A Pilot Study
Felix Mahfoud;Markus Schlaich;Ingrid Kindermann;Christian Ukena.
2013 ESH/ESC Practice guidelines for the management of arterial hypertension
Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon.
Blood Pressure (2014)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: